Sort
50,496 grants matching “lung cancer”
Predictors of CVD among breast cancer survivors in an integrated health system
$616,377Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2017 · CA
Validating and Characterizing a New Melanoma Therapeutic Target
$616,207Sara A Courtneidge · Oregon Health & Science University · R01 · FY2019 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$616,200Edward B Garon · University Of California Los Angeles · R01 · FY2019 · CA
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
$616,177Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2024 · CA
SMART Cancer Care Teams: Enhancing EHR Communication to Improve Interprofessional Teamwork
$616,123Shin-Ping Tu · University Of California At Davis · R01 · FY2024 · CA
Expression signatures of TB-specific memory responses within the human lung
$616,090Richard F Silver · Case Western Reserve University · R01 · FY2015 · HL
Developing purinergic receptor inverse agonists for treating triple negative breast cancer
$616,071Jean X Jiang · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$616,064Wendy M Leisenring · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers
$616,064Henning Willers · Massachusetts General Hospital · U01 · FY2020 · CA
Impact of mutation burden on cancer growth and the immune landscape
$615,901Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Diversity of the Tumor Microenvironment in Cancer Progression and Metastasis
$615,883Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2014 · CA
Design and characterization of bacterial population dynamics in solid tumor models
$615,868Jeff M Hasty · University Of California, San Diego · R01 · FY2024 · EB
A Randomized Trial of Incentives for Research Participation
$615,864Scott D Halpern · University Of Pennsylvania · R01 · FY2017 · CA
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$615,852Yun Wu · State University Of New York At Buffalo · R01 · FY2024 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$615,820Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Smoking cessation in lung cancer screening: integrated digital/clinical approach
$615,792J Taylor Hays · Mayo Clinic Rochester · R01 · FY2016 · CA
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
$615,683David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2018 · CA
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
$615,683David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
$615,683David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation
$615,659Michael B. Steinberg · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Adversarially Based Virtual CT Workflow for Evaluation of AI in Medical Imaging
$615,638Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2023 · EB
Determinants of acquired resistance in small cell lung cancer
$615,628Charles M Rudin · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Validation and extension of an existing risk model for lung cancer
$615,470Randa A El-Zein · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$615,450Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
$615,425John V. Heymach · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA